[go: up one dir, main page]

WO2013025073A3 - 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 - Google Patents

유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2013025073A3
WO2013025073A3 PCT/KR2012/006541 KR2012006541W WO2013025073A3 WO 2013025073 A3 WO2013025073 A3 WO 2013025073A3 KR 2012006541 W KR2012006541 W KR 2012006541W WO 2013025073 A3 WO2013025073 A3 WO 2013025073A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
treating diabetes
extract
composition
diabetes complications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/006541
Other languages
English (en)
French (fr)
Other versions
WO2013025073A2 (ko
Inventor
정봉현
김문일
이소연
이의진
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Bioscience and Biotechnology KRIBB
Original Assignee
Korea Research Institute of Bioscience and Biotechnology KRIBB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Research Institute of Bioscience and Biotechnology KRIBB filed Critical Korea Research Institute of Bioscience and Biotechnology KRIBB
Publication of WO2013025073A2 publication Critical patent/WO2013025073A2/ko
Publication of WO2013025073A3 publication Critical patent/WO2013025073A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물에 관한 것으로, 더욱 자세하게는 유홍초 추출물을 함유하는 당뇨병 합병증 예방 또는 치료용 약학조성물 및 건강기능식품에 관한 것이다. 본 발명에 따른 조성물은 혈당 강하 및 뇨단백 저해 작용을 나타내어, 당뇨합병증의 예방 또는 치료에 탁월한 효과를 가진다.
PCT/KR2012/006541 2011-08-17 2012-08-17 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 Ceased WO2013025073A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110081857 2011-08-17
KR10-2011-0081857 2011-08-17

Publications (2)

Publication Number Publication Date
WO2013025073A2 WO2013025073A2 (ko) 2013-02-21
WO2013025073A3 true WO2013025073A3 (ko) 2013-05-30

Family

ID=47715611

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/006541 Ceased WO2013025073A2 (ko) 2011-08-17 2012-08-17 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물

Country Status (2)

Country Link
KR (1) KR20130020623A (ko)
WO (1) WO2013025073A2 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103961626A (zh) * 2014-03-28 2014-08-06 南阳医学高等专科学校 治疗眼底出血的中草药丸

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101550390B1 (ko) * 2011-08-18 2015-09-08 한국생명공학연구원 유홍초속에서 분리한 신규화합물 및 이를 유효성분으로 포함하는 당뇨병의 예방 또는 치료용 조성물
CN104623406B (zh) * 2014-12-11 2018-01-16 苏风军 治疗虹膜睫状体炎的中药方剂
CN104906514A (zh) * 2015-06-23 2015-09-16 包晓娜 一种治疗眩晕的中药组合物
US11020405B2 (en) 2017-09-25 2021-06-01 Kangwon National University University-Industry Cooperation Foundation Method for prevention or treatment of diabetic complications
KR101938991B1 (ko) 2017-09-25 2019-01-15 강원대학교산학협력단 당뇨병성 합병증의 예방 또는 치료용 약제학적 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110095835A (ko) * 2010-02-19 2011-08-25 한국생명공학연구원 둥근잎유홍초 추출물을 함유하는 당뇨병 치료용 약학적 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110095835A (ko) * 2010-02-19 2011-08-25 한국생명공학연구원 둥근잎유홍초 추출물을 함유하는 당뇨병 치료용 약학적 조성물

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MASATERU, ONO ET AL.: "Two New Glycosidic Acids, Quamoclinic Acids G and H of the Resin Glycosides (Convolvulin) from the Seeds of Quamoclit pennata", CHEM. PHARM. BULLETIN, vol. 58, no. 9, June 2010 (2010-06-01), pages 1232 - 1235 *
NAOKI ASANO ET AL.: "dihydroxynortropane alkaloids from calystegine-producing plants", PHYTOCHEMISTRY, vol. 57, no. ISSUE, July 2001 (2001-07-01), pages 721 - 726 *
RAJENDRAN, K. ET AL.: "Pharmacognostical Identification of Stem and Root of Ipomoea quamoclit(Linn.)", NATURAL PRODUCT SCIENCES, vol. 13, no. 4, 2007, pages 273 - 278 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103961626A (zh) * 2014-03-28 2014-08-06 南阳医学高等专科学校 治疗眼底出血的中草药丸
CN103961626B (zh) * 2014-03-28 2017-06-20 南阳医学高等专科学校 治疗眼底出血的中草药丸

Also Published As

Publication number Publication date
KR20130020623A (ko) 2013-02-27
WO2013025073A2 (ko) 2013-02-21

Similar Documents

Publication Publication Date Title
ZA201503110B (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
WO2012033378A3 (ko) 비만억제 활성과 혈당강하 효능이 있는 꾸지뽕 및 의이인을 포함하는 조성물 및 이의 용도
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
HK1211231A1 (en) Exendin-4 derivatives
WO2009055331A3 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
WO2012108689A3 (ko) 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도
WO2009153496A3 (fr) Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies
WO2013025073A3 (ko) 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물
PH12015502263A1 (en) Composition for preventing or treating hangover
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
WO2012108677A3 (ko) 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도
WO2011095882A8 (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2010094837A3 (en) Sugar product
WO2011014520A3 (en) Compounds and compositions as modulators of gpr119 activity
WO2011102690A3 (ko) 둥근잎유홍초 추출물을 함유하는 당뇨병 치료용 약학적 조성물
WO2010104281A3 (ko) 아토피성 피부질환 개선용 조성물
WO2016190566A3 (ko) 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품
WO2013000895A9 (en) Dha and epa in the reduction of oxidative stress
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
WO2011156820A9 (en) Compositions, methods and uses for treatment of type 1 diabetes
WO2012105816A3 (ko) 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
WO2012138146A3 (ko) 돌콩의 열처리분말 또는 추출물을 유효성분으로 하는 당뇨병 및 당뇨합병증의 예방 및 치료를 위한 조성물
WO2012102560A3 (ko) 신규한 4-ｏ-메틸호노키올 유도체 및 이를 유효성분으로 포함하는 염증질환 치료용 조성물
WO2011013999A3 (ko) 키토올리고당을 함유하는 피로회복용 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12823810

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12823810

Country of ref document: EP

Kind code of ref document: A2